Safety and Efficacy of Iodine-131 Anti-B1 Antibody for Intermediate Grade Non-Hodgkin's Lymphoma Following First Line CHOP

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by:
Corixa Corporation
ClinicalTrials.gov Identifier:
NCT00022932
First received: August 16, 2001
Last updated: June 23, 2005
Last verified: September 2004
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Study Completion Date: No date given
  Primary Completion Date: No date given